DOT1L is the only known histone 3 lysine 79 (H3K79) methyltransferase, while AML or acute lymphocytic leukemia (ALL) is a malignant clonal disease of hematopoietic stem cells, and without any special treatment, these patients can only survive for about 3 months. Here, DOT1L is linked to acute lymphoblastic leukemia.